hospitalpharmacyeurope.com Report : Visit Site

Technical data of the hospitalpharmacyeurope.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host hospitalpharmacyeurope.com. Currently, hosted in United States and its service provider is E.I. du Pont de Nemours and Co. Inc. .

the related websites

dailymail.co.uk bbc.co.uk legalgenealogist.com bda.org msn.com bharatstudent.com advancednetting.co.uk dailyrecord.co.uk innerself.com shop.bsigroup.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.6 (CentOS) PHP/5.4.16 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

 this site is intended for health professionals only subscribe twitter linked in 487 thursday 14 june 2018 sign in forgotten your password -- newsletter -- home news blogs latest issue supplements events handbooks elearning advertise subscribe search this site: practical therapeutics oncology safety conference reports technology hazardous opinion patient care policy & practice respiratory research you are here: home prostate cancer saliva test to start trials taking aspirin could help prevent bowel cancer cancer research uk tests first of its kind vaccine to treat lung cancer nice draft guidance rejects first-line use of cabometyx blogs bernard naughton mpharm (hons), mrpharms, dip clin pharm blog: the falsified medicines directive (fmd) pilot: medicine authentication technology in a hospital setting trudi hilton blog: pharmaciens sans frontiers 11.11.16: founded in 1985 to retrieve unused drugs from chemists for use in developing countries, pharmaciens sans frontières comité international extended its objectives to help the developing countries set up a local adapted health care system see more articles top stories most commented prostate cancer saliva test to start trials 14.06.18: international team of researchers have developed new dna test to identify men at greatest risk of prostate cancer taking aspirin could help prevent bowel cancer 14.06.18: cancer fighting effects of aspirin revealed in bowel tumour study cancer research uk tests first of its kind vaccine to treat lung cancer 12.06.18: a first of its kind treatment vaccine has moved into a phase i clinical trial for patients with non-small cell lung cancer (nsclc),... nice draft guidance rejects first-line use of cabometyx 06.06.18: evidence on whether cabozantinib increases the overall length of time people live is “less certain” says the national institute for... most read women with hiv lack support during menopause 18.05.18: nearly half of women with hiv lack help to manage menopause, a new study finds nice recommendation gives three more treatment options for people with blood cancer 10.05.18: blood cancer drugs brentuximab, vedotin, midostaurin will now be available on the nhs giving hundreds of individuals more therapy... herzuma now available in europe 04.05.18: herzuma is the third biosimilar to be marketed and distributed by the mundipharma network in europe nice final appraisal determination for guselkumab to treat moderate to severe plaque psoriasis 04.05.18: <p>the nice decision will result in quicker access for patients to the first selective<br /> il-23 inhibitor</p> see more articles industry news positive chmp opinion for akcea orphan drug inotersen 04.06.18: tegsedi has been approved by the ema for treatment of stage 1 and 2 polyneuropathy in adults with hereditary transthyretin amyloidosis global immuno-oncology partnership announced 06.04.18: boehringer ingelheim and ose immunotherapeutics enter into a global license and collaboration agreement in immuno-oncology to develop... launch of two new joint working projects with national cancer vanguard sites 20.03.18: initiatives will use data analysis to identify ways to improve care and access to services for patients across multiple types of... see more articles latest roundtables hpe advisory boards/roundtables provide exclusive and valuable insight into the factors that influence hospital pharmacists. please see below for the latest meeting reports. latest roundtables see all roundtables latest supplements hpe supplements are created to provide readers with dedicated resources and materials for specific areas of hospital pharmacy. click on the images below to access the latest supplements. latest supplements see all supplements latest handbooks hpe handbooks are created to provide readers with dedicated resources and materials for specific areas of hospital pharmacy. click on the images below to access the latest handbooks. latest handbooks see all handbooks tweets by @hpe_magazine advertorial features cstds prevent microbial ingress a second-generation closed system transfer device both provides effective containment of... © cogora 2018 advertise site map accessibility terms & conditions privacy policy contact us before you begin information on this website is exclusively for health care professionals and not the general public. are you a qualified secondary-care pharmacist or healthcare professional? content unavailable we're sorry, but information on this website is exclusively for health care professionals and not the general public. you are leaving www.nursinginpractice.com you are currently leaving the nursing in practice site. are you sure you want to proceed? respect for nurses: sign up to our e-petition today the nursing in practice respect campaign is now live! over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the uk. as part of our campaign, nursing in practice is looking to call on parliament to set up a debate to celebrate the vital work that you do. get involved: sign our e-petition calling all primary care nurses! 'like' our nursing in practice facebook page to enter our free draw to win a £25 m&s; voucher http://www.facebook.com/nursinginpracticemagazine

URL analysis for hospitalpharmacyeurope.com

http://www.hospitalpharmacyeurope.com///content/accessibility
http://www.hospitalpharmacyeurope.com///site-map
http://www.hospitalpharmacyeurope.com///roundtables
http://www.hospitalpharmacyeurope.com///latest-issue
http://www.hospitalpharmacyeurope.com///user?destination=
http://www.hospitalpharmacyeurope.com///journal
http://www.hospitalpharmacyeurope.com///policy-practice
http://www.hospitalpharmacyeurope.com///content/terms-and-conditions
http://www.hospitalpharmacyeurope.com///signup-newsletter
http://www.hospitalpharmacyeurope.com///editors-pick/global-immuno-oncology-partnership-announced
http://www.hospitalpharmacyeurope.com///events
http://www.hospitalpharmacyeurope.com///content/advertise
http://www.hospitalpharmacyeurope.com///article_hub/blogs
http://www.hospitalpharmacyeurope.com///editors-pick/launch-two-new-joint-working-projects-national-cancer-vanguard-sites
http://www.hospitalpharmacyeurope.com///technology
epetitions.direct.gov.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Whois Server Version 2.0

Domain names in the .com and .net domains can now be registered
with many different competing registrars. Go to http://www.internic.net
for detailed information.

Domain Name: HOSPITALPHARMACYEUROPE.COM
Registrar: GANDI SAS
Sponsoring Registrar IANA ID: 81
Whois Server: whois.gandi.net
Referral URL: http://www.gandi.net
Name Server: A.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name Server: C.DNS.GANDI.NET
Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Updated Date: 10-oct-2016
Creation Date: 20-mar-2003
Expiration Date: 20-mar-2019

>>> Last update of whois database: 2017-07-17T01:35:20Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR GANDI SAS

  REFERRER http://www.gandi.net

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =hospitalpharmacyeurope.com

  PORT 43

  SERVER whois.gandi.net

  ARGS hospitalpharmacyeurope.com

  PORT 43

  TYPE domain

DOMAIN

  NAME hospitalpharmacyeurope.com

NSERVER

  A.DNS.GANDI.NET 173.246.98.1

  B.DNS.GANDI.NET 213.167.229.1

  C.DNS.GANDI.NET 217.70.179.1

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

  CHANGED 2016-10-10

  CREATED 2003-03-20

  EXPIRES 2019-03-20

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .